Vereflu from Veredus Laboratories can detect various flu subtypes in one test.
The threat of an influenza pandemic propels the need of a fast and reliable test for the detection of seasonal human influenza, with the capability to identify and differentiate flu subtypes. In patients with suspected pandemic flu, rapid identification of patients who will develop severe symptoms is critical for effective management and positive outcome. When used on patients at the earliest stages of disease, these tests will have prognostic value, rapidly identifying those who are suffering from seasonal flu from those who are suffering from pandemic flu. This will lead to better resource management through more efficient allocation of limited supplies of vaccines, diagnostic ests, hospital beds, quarantine facilities, as well as manpower in terms of health care workers.